Westra Jantine L, Boven Ludolf G, van der Vlies Pieter, Faber Hendrika, Sikkema Birgit, Schaapveld Michael, Dijkhuizen Trijnie, Hollema Harry, Buys Charles H C M, Plukker John T M, Kok Klaas, Hofstra Robert M W
Department of Medical Genetics, University of Groningen, The Netherlands.
Genes Chromosomes Cancer. 2005 Jun;43(2):194-201. doi: 10.1002/gcc.20148.
Chromosomal instability in colon tumors implies the presence of numerical and structural chromosome aberrations and is further characterized by the absence of microsatellite instability and the occurrence of KRAS and/or TP53 mutations. In a previous screening of 194 colon tumors for both microsatellite instability and TP53 mutation, we found 25 microsatellite-unstable tumors, in 9 (36%) of which, presumed to be chromosomally stable, there were TP53 mutations. This prompted us to investigate whether a TP53 mutation in these microsatellite-unstable tumors would be an indicator of chromosomal instability, that is, whether this would be a category of tumors showing both microsatellite and chromosomal instability. For chromosomal instability assessment, we performed array-comparative genomic hybridization analysis of tumor and control DNA extracted from formalin-fixed, paraffin-embedded stage III colon tumor specimens. The array consisted of 435 subtelomere-specific BACs. We compared all but one (whose DNA was of bad quality) of the microsatellite-unstable TP53 mutation-containing tumors (8) with a similarly sized group of microsatellite-unstable tumors without TP53 mutation (11). Microsatellite-unstable tumors with a TP53 mutation showed on average 0.9 aberrations (range 0-3) when assessed with this array system. Those without a TP53 mutation showed on average 0.7 aberrations (range 0-2). Thus, microsatellite-unstable tumors showed few chromosomal abnormalities regardless of TP53 mutation status. Because, in our study, the microsatellite-stable tumors had on average 3.4chromosomal abnormalities (range 0-7), a clear difference exists between microsatellite-unstable and -stable tumors. Because a substantial proportion of microsatellite-unstable colon tumors carry a TP53 mutation while showing relativelyfewchromosomal aberrations, a TP53 mutation in these tumors cannot be considered to be an indicator of chromosomal instability.
结肠肿瘤中的染色体不稳定性意味着存在染色体数目和结构畸变,其进一步特征为无微卫星不稳定性以及KRAS和/或TP53突变的发生。在之前对194例结肠肿瘤进行微卫星不稳定性和TP53突变筛查时,我们发现了25例微卫星不稳定肿瘤,其中9例(36%)被推测为染色体稳定,但存在TP53突变。这促使我们研究这些微卫星不稳定肿瘤中的TP53突变是否会是染色体不稳定性的一个指标,即这是否会是一类同时表现出微卫星和染色体不稳定性的肿瘤。为了评估染色体不稳定性,我们对从福尔马林固定、石蜡包埋的III期结肠肿瘤标本中提取的肿瘤和对照DNA进行了阵列比较基因组杂交分析。该阵列由435个亚端粒特异性BAC组成。我们将除1例(其DNA质量较差)外的所有含TP53突变的微卫星不稳定肿瘤(8例)与一组大小相似但无TP53突变的微卫星不稳定肿瘤(11例)进行了比较。使用该阵列系统评估时,有TP53突变的微卫星不稳定肿瘤平均显示0.9个畸变(范围为0 - 3)。无TP53突变的肿瘤平均显示0.7个畸变(范围为0 - 2)。因此,无论TP53突变状态如何,微卫星不稳定肿瘤显示出的染色体异常都很少。由于在我们的研究中,微卫星稳定肿瘤平均有3.4个染色体异常(范围为0 - 7),微卫星不稳定和稳定肿瘤之间存在明显差异。因为相当一部分微卫星不稳定的结肠肿瘤携带TP53突变,同时显示出相对较少的染色体畸变,所以这些肿瘤中的TP53突变不能被认为是染色体不稳定性的一个指标。